Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02875015 · ClinicalTrials.gov registry record · NA
Liposomal Bupivacaine vs. Bupivacaine Hydrochloride and Lidocaine During Suburethral Sling Placement
A NA study, sponsored by Atlantic Health System.
- Completed
- Registry status
- NA
- Development phase
- 57
- Enrollment target
NCT02875015 is a NA study that has completed, run by Atlantic Health System. The registered enrollment target is 57 participants.
The verdict
NCT02875015, a NA study, has completed, sponsored by Atlantic Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
Study Summary
Postoperative pain, the quality of their recovery and the opioid consumption following a midurethral sling placement are being compared between 2 groups. One group will have the hydro-dissection performed with a diluted liposomal bupivacaine solution. The other group will have the hydro-dissection performed with a diluted bupivacaine HCL and Lidocaine solution.
Interventions
- DRUG Liposomal Bupivacaine
- DRUG Bupivacaine Hydrochloride and Lidocaine
- PROCEDURE Suburethral Sling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2016-04 |
| Est. Completion | 2018-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02875015
The ClinicalTrials.gov registry entry for NCT02875015 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Atlantic Health System, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Liposomal Bupivacaine is the first listed.
NCT02875015 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02875015 about?
NCT02875015 is a clinical study titled "Liposomal Bupivacaine vs. Bupivacaine Hydrochloride and Lidocaine During Suburethral Sling Placement". Postoperative pain, the quality of their recovery and the opioid consumption following a midurethral sling placement are being compared between 2 groups. One group will have the hydro-dissection performed with a diluted liposomal bupivacaine solution. The other group will have the hydro-dissection p...
What is the current status of trial NCT02875015?
This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2016-04. Estimated completion is 2018-05.
What interventions are being tested in trial NCT02875015?
The interventions under investigation include: Liposomal Bupivacaine (DRUG), Bupivacaine Hydrochloride and Lidocaine (DRUG), Suburethral Sling (PROCEDURE).
Who is sponsoring clinical trial NCT02875015?
This trial is sponsored by Atlantic Health System, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.